Latest Cost Reduction News

Telstra Group Limited reported solid half-year results for December 2025, with revenue and profit growth underpinning a higher dividend and an expanded share buy-back program. The company’s Connected Future 30 strategy continues to drive operational momentum amid disciplined cost management.

Healius Limited reported solid half-year results for 1H26, with revenue growth driven by pathology and Agilex Biolabs, alongside significant progress in digital transformation and AI integration.

Spark New Zealand’s H1 FY26 results reveal a strong rebound in profitability driven by mobile service revenue growth and disciplined cost reductions, alongside the strategic sale of its data centre business.

Botanix Pharmaceuticals has launched a A$45 million capital raising to support the expansion of its dermatology product Sofdra®, while negotiating to reduce active pharmaceutical ingredient costs by up to 40%. The raising includes a two-tranche placement and a security purchase plan, with options offered to investors.

Botanix Pharmaceuticals has secured approximately A$45 million through a two-tranche placement and an underwritten security purchase plan to fund API purchases, derisk its supply chain, and accelerate growth of its flagship product Sofdra.

Centaurus Metals has successfully produced over half a tonne of high-grade direct reduction pellet feed from its Jambreiro Iron Ore Project, confirming the product's quality and advancing off-take discussions.

Temas Resources has inked a Letter of Intent to validate its patented Regenerative Chloride Leach technology on a major refractory gold deposit, paving the way for a joint venture to commercialise the platform in Western North America.

Identitii Limited is sunsetting its legacy Overlay+ platform to concentrate on BNDRY, aiming to improve cash flow and accelerate profitability amid growing demand in the clubs and pubs sector.

Genesis Minerals has announced a recommended court-approved scheme to acquire Magnetic Resources for A$639 million, significantly expanding its resource base and production outlook. The acquisition includes the high-grade Lady Julie project near Genesis’ Laverton mill, promising operational synergies and supporting an aspirational 500,000 ounces per annum production target.

Elixinol Wellness reported a 9.5% revenue increase in Q4 FY25 alongside a 30% reduction in operating costs, setting a clear path to profitability under fresh executive leadership.

AMP Limited reported a robust FY25 with underlying NPAT up 20.8%, driven by strong cashflow growth, cost reductions, and new product launches including AMP Bank GO and AMP Lifetime Pension. The company sets a steady course for FY26 with continued focus on retirement solutions and AI-driven innovation.

Orora Limited reported a robust 32.2% rise in underlying net profit after tax for the half-year ended December 2025, underpinned by strong volume growth in its Cans segment and operational efficiencies across its glass businesses. The company also completed a $227.4 million share buyback in 2025 and announced a fresh $270 million on-market buyback program.